(Gynecologic Oncology Reports 2025 review, 2025-08: Review of the preclinical and clinical data for ivermectin in gynaecologic cancers, summarising ovarian and endometrial laboratory findings and cautioning that non-human model results often do not translate to human efficacy.
However, findings in non-human models often do not translate into human efficacy due to the complexity of human physiology.
n/a (HTML full text)
(Gynecologic Oncology Reports 2025 review, 2025-08: Review of the preclinical and clinical data for ivermectin in gynaecologic cancers, summarising ovarian and endometrial laboratory findings and cautioning that non-human model results often do not translate to human efficacy. Study type: narrative review. N: not stated. Country: USA (Atrium Health Levine Cancer Institute, Charlotte NC). Dose/route/schedule: n/a. Funder/COI: see PMC12369425 (declared none). Comparator: n/a. The review also notes that most evidence is in vitro or organoid-level. Also filed as IVD-36, IVD-48 (claims C1, C6, C7). Study type: review.
